Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

133

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

LSD analogue with potential for treating schizophrenia

Related Posts

A skin-hypothalamus axis couples heat stress and metabolic dysfunction

A skin-hypothalamus axis couples heat stress and metabo...

75

Brain endothelial gap junction coupling enables rapid vasodilation propagation during neurovascular coupling

Brain endothelial gap junction coupling enables rapid v...

109

Glycosphingolipids in cell identity: Biosynthesis, functions, and emerging tools

Glycosphingolipids in cell identity: Biosynthesis, func...

47